Prevalence of hepatitis B and hepatitis C in patients referred to health centers in the Hamadan province, Iran: an epidemiologic study of infections between 2004 and 2007

1. World Health Organization. Hepatitis C: global prevalence. Wkly Epidemiol Rec. 1997; 2:341-4.Search in Google Scholar

2. McHutchison JG. Understanding Hepatitis C. Am J Manag Care. 2004; 10:S21-29.Search in Google Scholar

3. Nair S, Perillo RP. Hepatitis B and D. In: Zakim D, Boyer TD, eds. Hepatology. 4th ed. Philadelphia: Saunders, 2003.Search in Google Scholar

4. Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol. 2007; 13:74-81.10.3748/wjg.v13.i1.74Open DOISearch in Google Scholar

5. Hu KQ, Yang H, Lin YC, Lindsay KL, Redeker AG. Clinical profiles of chronic Hepatitis C in a major county medical center outpatient setting in United States. Int J Med Sci. 2004; 1:92-100.10.7150/ijms.1.92Open DOISearch in Google Scholar

6. Alter M. Epidemiology of hepatitis B infec-tion in the Western Pacific and South-East Asia. Gut. 1976; 38 (suppl. 2):S18-23.10.1136/gut.38.Suppl_2.S18Search in Google Scholar

7. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004; 127: S27-34.10.1053/j.gastro.2004.09.013Open DOISearch in Google Scholar

8. Wang CS, Chang TT, Yao WJ, Chou P. Comparison of Hepatitis B Virus and Hepatitis C Virus prevalence and risk factors in a community-based study. Am J Trop Med Hyg. 2002; 66:389-93.10.4269/ajtmh.2002.66.389Search in Google Scholar

9. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med. 1996; 334:1691-6.10.1056/NEJM199606273342602Open DOISearch in Google Scholar

10. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 1992; 327:1899-905.10.1056/NEJM199212313272702Open DOISearch in Google Scholar

11. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: A casecontrol study. J Gastroenterol and Hepatol. 2002; 17: 1092-7.10.1046/j.1440-1746.2002.02843.xOpen DOISearch in Google Scholar

12. Cooreman MP, Schoondermark-Van de Ven EM. Hepatitis C virus: biological and clinical consequences of genetic heterogeneity. Scand J Gastroenterol. 1996; Suppl. 218:106-15.10.3109/00365529609094740Search in Google Scholar

13. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepatitis Monthly. 2008; 8:281-94.Search in Google Scholar

14. Lolekha S, Warachit B, Hirunyachote A, Bowonkiratikachorn P, West DJ, Poerschke G. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand. Vaccine. 2002; 20:3739-43.10.1016/S0264-410X(02)00358-4Open DOISearch in Google Scholar

15. Arslanoglu I, Cetin B, Isguven P, Karavus M. Anti- HBs response to standard hepatitis B vaccination in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Metab. 2002; 15:389-95.10.1515/JPEM.2002.15.4.38912008685Open DOISearch in Google Scholar

16. Cook IF, Murtagh J. Comparative immunogenicity of hepatitis B vaccine administered into the ventrogluteal area and anterolateral thigh in infants. J Paediatr Child Health. 2002; 38:393-6.10.1046/j.1440-1754.2002.00013.x12174003Open DOISearch in Google Scholar

17. Farhat A, Khademi G, Mazouman SJ. The prevalence of hepatitis B carrier state in Khorasan province of Iran. Saudi Med J. 2003; 24:549-51.Search in Google Scholar

18. Amini S Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population-based study. J Trop Med Hyg. 1993; 96:277-87.Search in Google Scholar

19. Mojtahedzadeh SM. Prevalence of HBsAg and VDRL positive cases in Hamadan province blood donors. Journal of research in medicine, Shaheed Beheshti University of Medical Sciences, 1995; 3,4:74 [Article in Persian language].Search in Google Scholar

20. Othman BM, Monem FS. Prevalence of hepatitis virus antibodies among intravenous drug abusers and prostitutes in Damascus, Syria. Saudi Med J. 2002; 23: 393-5.Search in Google Scholar

21. Haider NA. Prevalence of HBV and C among blood donors and high risk groups in Hajjah, Yemen Republic. Saudi Med J. 2002; 23:1090-4.Search in Google Scholar

22. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg. 2003; 49: 440-7.10.4269/ajtmh.1993.49.4407692754Search in Google Scholar

23. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion transmissible infections in North Indian voluntary and replacement blood donors: prevalence and trends, 1989-1996. Vox Sang. 1997; 73:70-3.10.1046/j.1423-0410.1997.7320070.x9304774Open DOISearch in Google Scholar

24. Khokhar N, Gill ML, Malik GJ. General se--roprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak. 2004; 14:534-6.Search in Google Scholar

25. Ashgar A. Prevalence of hepatitis B virus genotype in Saudi Arabia: a preliminary report. Indian J Gastroenterol. 2008; 27:81-2. Search in Google Scholar